The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
The ten-day initiative, running from 10 to 21 November, brings together a team of highly skilled German doctors providing life-changing reconstructive surgeries at no cost
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
The FDA setback highlights ongoing tensions between patient needs, regulatory processes, and the use of real-world evidence in evaluating treatments for rare diseases
Subscribe To Our Newsletter & Stay Updated
